Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Gynecologic Cancer Gynecologic Cancer for March/April 2020 Update confirms survival benefit with trastuzumab in uterine serous carcinoma, Survey reveals gender pay discrepancies among gyn-oncs, Most endometrial cancers treated with minimally invasive procedures, Breastfeeding reduces invasive ovarian cancer risk, Combo elicits responses in advanced cervical cancer, More must reads Gynecologic Cancer for January/February 2020 Pelvic insufficiency fractures are common after chemoradiotherapy for cervical cancer, More must readsGynecologic Cancer for November/December 2019 Surgical Staging Improves Cervical Cancer Outcomes, More must readsGynecologic Cancer for September/October 2019 PAOLA-1/ENGOT-ov25 trial: PARP inhibitor for maintenance improves PFS in advanced ovarian cancer, Closure of women’s health clinics may negatively impact cervical cancer outcomes, Nivolumab may be beneficial for recurrent or metastatic cervical cancer, More must readsGynecologic Cancer for July/August 2019 Ovarian Cancer Diagnosed and Treated Earlier Under ACA, Patient-Provider Survivorship Communication Gaps Persist, Vaginal microbiota composition linked to ovarian cancer risk, More must readsPages« first 1 2 3 4 5 6 7 last »
